Abstract Details

Title Leukocyte Dynamics Following Alemtuzumab Treatment of Relapsing-Remitting Multiple Sclerosis in a Phase 2 Study (CAMMS223)

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 172

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alasdair Coles, MD, PhD (University of Cambridge)	Dr. Coles has nothing to disclose.
Dimitrios I. Zafeiriou, MD, PhD	No disclosure on file

��ɫ��